摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3S,9aS)-tert-butyl 3-(4-methyl-1-oxo-1,3-dihydroisobenzofuran-5-yl)hexahydro-1H-pyrazino[1,2-a]pyrazine-2(6H)-carboxylate | 1443737-15-2

中文名称
——
中文别名
——
英文名称
(3S,9aS)-tert-butyl 3-(4-methyl-1-oxo-1,3-dihydroisobenzofuran-5-yl)hexahydro-1H-pyrazino[1,2-a]pyrazine-2(6H)-carboxylate
英文别名
tert-butyl (3S,9aS)-3-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)-1,3,4,6,7,8,9,9a-octahydropyrazino[1,2-a]pyrazine-2-carboxylate
(3S,9aS)-tert-butyl 3-(4-methyl-1-oxo-1,3-dihydroisobenzofuran-5-yl)hexahydro-1H-pyrazino[1,2-a]pyrazine-2(6H)-carboxylate化学式
CAS
1443737-15-2
化学式
C21H29N3O4
mdl
——
分子量
387.479
InChiKey
YVCINHMISHHGMB-KBXCAEBGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    28
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    71.1
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL<br/>[FR] INHIBITEURS DU CANAL À POTASSIUM DE LA MEDULLA EXTERNE DU REIN
    申请人:MERCK SHARP & DOHME
    公开号:WO2013090271A1
    公开(公告)日:2013-06-20
    The present invention provides compounds of Formula (I) and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds act as diuretics and natriuretics and are valuable pharmaceutically active compounds for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension and conditions resulting from excessive salt and water retention.
    本发明提供了式(I)的化合物及其药用可接受的盐,这些化合物是ROMK(Kir1.1)通道的抑制剂。这些化合物作为利尿剂和钠利尿剂,并且是治疗和预防包括高血压在内的心血管疾病以及由过多盐分和水潴留导致的疾病的有价值的药用活性化合物。
  • [EN] INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL<br/>[FR] INHIBITEURS DU CANAL POTASSIQUE MÉDULLAIRE EXTERNE RÉNAL
    申请人:MERCK SHARP & DOHME
    公开号:WO2013028474A1
    公开(公告)日:2013-02-28
    The present invention provides compounds of Formula Ia and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and conditions associated with excessive salt and water retention.
    本发明提供了式Ia的化合物及其药用可接受的盐,这些化合物是ROMK(Kir1.1)通道的抑制剂。这些化合物可用作利尿剂和/或钠利尿剂,并用于治疗和预防包括高血压、心力衰竭以及与过多盐分和水分潴留有关的医疗状况等心血管疾病。
  • Inhibitors of the renal outer medullary potassium channel
    申请人:Pasternak Alexander
    公开号:US09062070B2
    公开(公告)日:2015-06-23
    The present invention provides compounds of Formula Ia and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and conditions associated with excessive salt and water retention.
    本发明提供公式Ia的化合物及其药学上可接受的盐,它们是ROMK (Kir1.1)通道的抑制剂。这些化合物可用作利尿和/或钠利尿剂,并用于治疗和预防包括高血压、心力衰竭和与过度盐和水潴留有关的医学状况在内的心血管疾病。
  • Inhibitors of the Renal Outer Medullary Potassium Channel
    申请人:Pasternak Alexander
    公开号:US20140206618A1
    公开(公告)日:2014-07-24
    The present invention provides compounds of Formula Ia and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and conditions associated with excessive salt and water retention.
    本发明提供了公式Ia及其药学上可接受的盐的化合物,它们是ROMK(Kir1.1)通道的抑制剂。这些化合物可用作利尿剂和/或钠利尿剂,并用于治疗和预防医疗状况,包括心血管疾病,如高血压,心力衰竭以及与过多盐和水潴留有关的病症。
  • US9062070B2
    申请人:——
    公开号:US9062070B2
    公开(公告)日:2015-06-23
查看更多